Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · IEX Real-Time Price · USD
2.850
-0.030 (-1.04%)
At close: Apr 25, 2024, 4:00 PM
2.880
+0.030 (1.05%)
After-hours: Apr 25, 2024, 4:53 PM EDT
Mersana Therapeutics Market Cap
Mersana Therapeutics has a market cap or net worth of $343.66 million as of April 25, 2024. Its market cap has decreased by -25.32% in one year.
Market Cap
343.66M
Enterprise Value
168.21M
1-Year Change
-25.32%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since June 28, 2017, Mersana Therapeutics's market cap has increased from $317.00M to $343.66M, an increase of 8.41%. That is a compound annual growth rate of 1.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 349.40M | -10.27% |
Apr 23, 2024 | 389.40M | 1.91% |
Apr 22, 2024 | 382.10M | -3.07% |
Apr 19, 2024 | 394.20M | -2.71% |
Apr 18, 2024 | 405.20M | -5.11% |
Apr 17, 2024 | 427.00M | -6.38% |
Apr 16, 2024 | 456.10M | -0.78% |
Apr 15, 2024 | 459.70M | -0.54% |
Apr 12, 2024 | 462.20M | 2.44% |
Apr 11, 2024 | 451.20M | 0.40% |
Apr 10, 2024 | 449.40M | -9.63% |
Apr 9, 2024 | 497.30M | -1.45% |
Apr 8, 2024 | 504.60M | -2.81% |
Apr 5, 2024 | 519.20M | 0.72% |
Apr 4, 2024 | 515.50M | -4.50% |
Apr 3, 2024 | 539.80M | 5.45% |
Apr 2, 2024 | 511.90M | -4.53% |
Apr 1, 2024 | 536.20M | -1.32% |
Mar 28, 2024 | 543.40M | -0.24% |
Mar 27, 2024 | 544.70M | 4.43% |
Mar 26, 2024 | 521.60M | 0.69% |
Mar 25, 2024 | 518.00M | -9.14% |
Mar 22, 2024 | 570.10M | -2.30% |
Mar 21, 2024 | 583.50M | -0.61% |
Mar 20, 2024 | 587.10M | -2.43% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ADC Therapeutics | 387.57M |
iTeos Therapeutics | 386.75M |
Cibus | 386.11M |
Biomea Fusion | 383.39M |
Anika Therapeutics | 379.93M |
Revance Therapeutics | 379.35M |
Pulse Biosciences | 378.29M |
Harrow Health | 374.84M |